Live: Will Ross Crush Q2 Earnings Tonight After Its Record Q1?

Media

Latest Articles

All Latest Articles

156716 Articles

Douglas A. McIntyre | Nov 29, 2006 at 1:24 PM EST

CNBC’s Charlie Gasparino Says Home Depot (HD) & New York Times (NYT) Could Be Acquired

CNBC’s Charlie Gasparino keyed in today on 2 potential takeout candidates today. His Street Stories Hank Greenberg may be engaged…

Douglas A. McIntyre | Nov 29, 2006 at 12:57 PM EST

Most Actives Under $5.00 Lagging the Horsemen by Far (Nov. 29, 2006)

As far as where the NASDAQ trading volume interest is, it isn’t even close. The Horsemen stocks are chugging along…

Douglas A. McIntyre | Nov 29, 2006 at 11:03 AM EST

Amazon Gets Downgraded (AMZN)

Amazon trades pretty much in the middle of its three year range. The stock hit $60 in mid-2003. It sits…

Douglas A. McIntyre | Nov 29, 2006 at 9:41 AM EST

Google Still Monkeying With Content Owners

Stocks: (GOOG) Google seems to take one step forward and two steps back in its dispute with content owners over…

Douglas A. McIntyre | Nov 29, 2006 at 9:33 AM EST

3Com Gets Poor Reception

Yesterday I keyed in about some concerns about 3Com (COMS) paying out $882 million for the other 49% of the…

Douglas A. McIntyre | Nov 29, 2006 at 8:32 AM EST

Pre-Market Stock News (Nov. 29, 2006)

(ABI) Abraxis Bio gets FDA approval for Amphicillin Injection.(AGN) Allergan up on Cramer from Mad Money.(AH) Armor Holdings wins another…

Douglas A. McIntyre | Nov 29, 2006 at 8:20 AM EST

Select Analyst Calls (Nov. 29, 2006)

ACV started as Neutral at Prudential.AMR started as Buya t Goldman Sachs.ANN cut to Neutral at UBS.BLDR started as Mkt…

Douglas A. McIntyre | Nov 29, 2006 at 7:54 AM EST

Citigroup: Prince Walid bin Talal’s Bad Hair Day

Saudi Prince Walid first put money into Citi in 1991. The stock was at about $2 then and trades at…

Douglas A. McIntyre | Nov 29, 2006 at 7:21 AM EST

Fifteen Most Overvalued Stocks: Merck

Merck’s stock price is fascinating The shares trade near their 52-week high, changing hands at almost $44. But, the company…

Douglas A. McIntyre | Nov 29, 2006 at 7:04 AM EST

...

From IPO Trader WLDN Posted by Bill in General pre ipo analysis on the entire calendar week in and week…

Douglas A. McIntyre | Nov 29, 2006 at 6:59 AM EST

Offshoring of Biotech Research to China

From BioHealth Investor by Andrew Vaino Interesting article in yesterday’s San Diego Union Tribune bemoaning the offshoring of biotech research…

Douglas A. McIntyre | Nov 29, 2006 at 6:58 AM EST

Anika Therapeutics Jumps 20% on FDA Letter

From BioHealth Investor Shares of Anika Therapeutics (ANIK) jumped more than 20% on Tuesday after the company announced it had…

Douglas A. McIntyre | Nov 29, 2006 at 6:56 AM EST

Essex Corp Volume Jumps 250%

From Volume Spike Investor Shares of Essex Corp.(KEYW) rose more than 1% on Tuesday as volume spiked 250% above the…

Douglas A. McIntyre | Nov 29, 2006 at 6:55 AM EST

Missed Allergan?

From The Average Joe Investor So I was watching Cramer last on Mad Money and heard his pitch on Allergan…

Douglas A. McIntyre | Nov 29, 2006 at 6:52 AM EST

David Strasser’s Catalysts That Make Lowe’s (LOW) A Buy

By Yaser Anwar, CSC of Equity Investment Ideas I happened to catch Mad Money last night where Cramer highlighted BAC’s…

1 … 10,416 10,417 10,418 10,419 10,420 … 10,448

Latest Articles

All Latest Articles

CNBC’s Charlie Gasparino Says Home Depot (HD) & New York Times (NYT) Could Be Acquired

Most Actives Under $5.00 Lagging the Horsemen by Far (Nov. 29, 2006)

Amazon Gets Downgraded (AMZN)

Google Still Monkeying With Content Owners

3Com Gets Poor Reception

Pre-Market Stock News (Nov. 29, 2006)

Select Analyst Calls (Nov. 29, 2006)

Citigroup: Prince Walid bin Talal’s Bad Hair Day

Fifteen Most Overvalued Stocks: Merck

...

Offshoring of Biotech Research to China

Anika Therapeutics Jumps 20% on FDA Letter

Essex Corp Volume Jumps 250%

Missed Allergan?

David Strasser’s Catalysts That Make Lowe’s (LOW) A Buy

Live: Will Ross Crush Q2 Earnings Tonight After Its Record Q1?

Coinbase Fell 50%. This 2X ETF Lost 85%. Here’s the Brutal Math a ‘Comeback’ Has to Overcome

Social Security’s Trust Fund Runs Dry in 2032. 3 Moves to Make Before Benefits Face a 22% Cut

His Medicare Advantage Trial Right Lasted 12 Months. At Month 14, Medigap Could Say No.

Social Security's Trust Fund Runs Dry in 2032. 3 Moves to Make Before Benefits Face a 22% Cut

His Medicare Advantage Trial Right Lasted 12 Months. At Month 14, Medigap Could Say No.

Coinbase Fell 50%. This 2X ETF Lost 85%. Here’s the Brutal Math a ‘Comeback’ Has to Overcome

Social Security’s Trust Fund Runs Dry in 2032. 3 Moves to Make Before Benefits Face a 22% Cut

Latest Articles

All Latest Articles

CNBC’s Charlie Gasparino Says Home Depot (HD) & New York Times (NYT) Could Be Acquired

Most Actives Under $5.00 Lagging the Horsemen by Far (Nov. 29, 2006)

Amazon Gets Downgraded (AMZN)

Google Still Monkeying With Content Owners

3Com Gets Poor Reception

Pre-Market Stock News (Nov. 29, 2006)

Select Analyst Calls (Nov. 29, 2006)

Citigroup: Prince Walid bin Talal’s Bad Hair Day

Fifteen Most Overvalued Stocks: Merck

...

Offshoring of Biotech Research to China

Anika Therapeutics Jumps 20% on FDA Letter

Essex Corp Volume Jumps 250%

Missed Allergan?

David Strasser’s Catalysts That Make Lowe’s (LOW) A Buy

Live: Will Ross Crush Q2 Earnings Tonight After Its Record Q1?

Coinbase Fell 50%. This 2X ETF Lost 85%. Here’s the Brutal Math a ‘Comeback’ Has to Overcome

Social Security’s Trust Fund Runs Dry in 2032. 3 Moves to Make Before Benefits Face a 22% Cut

His Medicare Advantage Trial Right Lasted 12 Months. At Month 14, Medigap Could Say No.

Featured Reads

Social Security's Trust Fund Runs Dry in 2032. 3 Moves to Make Before Benefits Face a 22% Cut

His Medicare Advantage Trial Right Lasted 12 Months. At Month 14, Medigap Could Say No.